The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
INTEGRATE: A randomized, phase II, double-blind, placebo-controlled study of regorafenib in refractory advanced oesophagogastric cancer (AOGC): A study by the Australasian Gastrointestinal Trials Group (AGITG)—Final overall and subgroup results.
 
Nick Pavlakis
Honoraria - AstraZeneca; Boehringer Ingelheim; Roche Pharma AG
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck Serono; Novartis; Pfizer; Roche Pharma AG
 
Katrin Marie Sjoquist
Travel, Accommodations, Expenses - Merck Serono
 
Eric Tsobanis
No Relationships to Disclose
 
Andrew James Martin
No Relationships to Disclose
 
Yoon-Koo Kang
Consulting or Advisory Role - Lilly/ImClone; Novartis; Ono Pharmaceutical; Roche/Genentech; Taiho Pharmaceutical
Research Funding - Bayer; Novartis; Roche/Genentech
 
Yung-Jue Bang
Consulting or Advisory Role - Bayer
Research Funding - Bayer
 
Christopher J. O'Callaghan
No Relationships to Disclose
 
Niall C. Tebbutt
Honoraria - Bayer
Consulting or Advisory Role - Bayer
 
Sun Young Rha
No Relationships to Disclose
 
Jeeyun Lee
No Relationships to Disclose
 
Jae Yong Cho
No Relationships to Disclose
 
Lara Rachel Lipton
No Relationships to Disclose
 
Margot J. Burnell
Other Relationship - Roche Pharma AG
 
Thierry Alcindor
No Relationships to Disclose
 
Andrew Strickland
No Relationships to Disclose
 
Jin Won Kim
No Relationships to Disclose
 
Sonia Yip
Honoraria - Lilly
 
John Simes
No Relationships to Disclose
 
John Raymond Zalcberg
Honoraria - Amgen; Bayer; Merck Serono; Pfizer; Roche Pharma AG; Specialised Therapeutics
Consulting or Advisory Role - Amgen; Bayer; Merck Serono; Pfizer; Roche Pharma AG; Specialised Therapeutics
Research Funding - Amgen; Bayer; Merck Serono; Novartis; Roche Pharma AG
Expert Testimony - Bayer
Travel, Accommodations, Expenses - Amgen; Bayer; Merck Serono; Roche Pharma AG; Specialised Therapeutics
 
David Goldstein
Stock and Other Ownership Interests - Sirtex Medical
Research Funding - Amgen (Inst); Celgene (Inst); pfizer (Inst)